Inari Medical, Inc.

Third quarter 2022 earnings conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on a touch-tone phone. To withdraw your question, please press star then two. Please note today's event is being recorded. I would now like to turn the conference over to Caroline Corner, Investor Relations. Please go ahead.

Thank you, Operator. Welcome to Inari's third quarter 2022 earnings call. Joining me on today's call are Bill Hoffman, President and Chief Executive Officer, Drew Hikes, Chief Operating Officer, and Mitchell, Chief Financial Officer. This call will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements made on this call that do not relate to matters of historical fact should be considered forward-looking statements including statements regarding the markets in which Inari operates, trends and expectations for Inari's products and technology, trends and demands for Inari's products, Inari's expected financial performance, expenses, and position in the market, and the impact of COVID-19 on Inari's operations and Inari's customer operations. These statements are neither promises nor guarantees and involve known and unknown risks and uncertainties that could cause actual results, performance, or achievement to differ materially from any results, performance, or achievement expressed or implied by the forward-looking statements. Please review INARI's most recent filings with the SEC, particularly the risk factors described in INARI's annual report on Form 10-K for the year ended December 31, 2021, for additional information. Any forward-looking statements provided during this call, including projections for future performance, are based on management's expectations as of today. INARI undertakes no obligation to update these statements except as required by applicable law. Inari's press release for third quarter 2022 results is available on Inari's website, www.inarimedical.com, under the investor section, and includes additional details about Inari's financial results. Inari's website also has the latest SEC filings, which you are encouraged to review. A recording of today's call will be available on Inari's website by 5 p.m. Pacific time today. Now I'd like to turn the call over to Bill for his comments on third quarter 2022 business highlights.

Thank you, Caroline, and thank you, everyone, for joining us today.